Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial.

Nina MagnoloThomas JaenickeAthanasios TsianakasWolfgang CzechDiamant Thaçi Andreas Pinter Delphine Kerob Samir Salah Thomas A Luger

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)

In patients with moderate to severe AD receiving systemic treatment, the Emollient 'plus' regimen significantly improved pruritus and quality of life items compared to the control, while using 23% less product over a 10-week period. These results stress the importance of daily use of emollients, especially emollients 'plus' to improve signs, symptoms and quality of life in patients with AD.

Keyphrases

atopic dermatitis
early onset
palliative care
depressive symptoms
drug induced
pain management